Rebien: We have an attractive location lined up for EMA

If the European Medicines Agency (EMA) moves to Denmark, the Danish government has a location lined up. But negotiations are omngoing and the Government is keeping its options open, says its special envoy, Lars Rebien Sørensen.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

Genmab søger om ny godkendelse hos EMA

I Europa vil Genmab nu til at have hovedproduktet, Darzalex, godkendt til førstelinjebehandling for knoglemarvskræft. Det udløser en ny milepælsbetaling fra partneren Janssen. (Opdateret 13.35)

Latest Top picks in English

Related articles